Overview

To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
1998-10-01
Target enrollment:
Participant gender:
Summary
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets under Fasting Conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Bupropion